Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Vertex Pharmaceuticals (Sweden) AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 5,249 Less Arrow 4,638 Less Arrow 4,412
Financial expenses 30 Less Arrow 10 Less Arrow 0
Earnings before taxes 345 Less Arrow 311 Less Arrow 304
EBITDA 415 Less Arrow 323 More Arrow 335
Total assets 2,939 More Arrow 5,889 Less Arrow 4,000
Current assets 2,915 More Arrow 5,819 Less Arrow 3,949
Current liabilities 1,464 More Arrow 4,673 Less Arrow 2,935
Equity capital 1,474 Less Arrow 1,216 Less Arrow 1,065
- share capital 5 Less Arrow 4 More Arrow 5
Employees (average) 9 Less Arrow 7 Equal arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 50.2% Less Arrow 20.6% More Arrow 26.6%
Turnover per employee 583 More Arrow 663 Less Arrow 630
Profit as a percentage of turnover 6.6% More Arrow 6.7% More Arrow 6.9%
Return on assets (ROA) 12.8% Less Arrow 5.5% More Arrow 7.6%
Current ratio 199.1% Less Arrow 124.5% More Arrow 134.5%
Return on equity (ROE) 23.4% More Arrow 25.6% More Arrow 28.5%
Change turnover 597 Less Arrow 583 Less Arrow -1,538
Change turnover % 13% More Arrow 14% Less Arrow -26%
Chg. No. of employees 2 Less Arrow 0 Less Arrow -1
Chg. No. of employees % 29% Less Arrow 0% Less Arrow -13%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.